Arizaga R L, Mangone C A, Allegri R F, Ollari J A
Memory Disorders Research Center and Neuroepidemiology Branch, National Institute of Social Services for Retirees, Buenos Aires, Argentina.
Alzheimer Dis Assoc Disord. 1999 Oct-Dec;13 Suppl 3:S201-5. doi: 10.1097/00002093-199912003-00028.
Population aging is a process that is especially accelerated in some parts of the world. One example is in Latin America. As with other developing regions, Latin America has to confront population "graying" in the context of an emerging economy. As a result of this and of their health history, the prevalence and incidence of age-related pathologies are different than those in the developed world. The burden of dementia is significant for patients, families, health systems, and public health. The aim of this paper was to summarize data from the scarce dementia epidemiological studies available in Latin America, the diagnostic criteria used in most countries and the most widely used diagnostic tools and neuropsychological assessment instruments (some of them translated, validated, and harmonized). Reference is made to the approval process and availability in Argentina of dementia and cognitive decline-related drugs.
人口老龄化是一个在世界某些地区尤其加速的过程。拉丁美洲就是一个例子。与其他发展中地区一样，拉丁美洲在新兴经济背景下不得不面对人口“老龄化”问题。由于这一情况及其健康史，与年龄相关疾病的患病率和发病率与发达国家不同。痴呆症给患者、家庭、卫生系统和公共卫生带来了沉重负担。本文的目的是总结拉丁美洲现有的稀缺痴呆症流行病学研究数据、大多数国家使用的诊断标准以及最广泛使用的诊断工具和神经心理学评估工具（其中一些已翻译、验证和统一）。文中还提及了阿根廷痴呆症和认知衰退相关药物的审批过程和可获得性。
